Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial
Top Cited Papers
- 12 February 2019
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 20 (4), 494-503
- https://doi.org/10.1016/s1470-2045(18)30896-9
Abstract
No abstract availableKeywords
Funding Information
- Radiation and Optometry Section of the Australian Government Department of Health (1060822)
This publication has 17 references indexed in Scilit:
- Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trialsThe Lancet Oncology, 2015
- High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancerRadiotherapy and Oncology, 2013
- Analysis of the impact of chest wall constraints on eligibility for a randomized trial of stereotactic body radiotherapy of peripheral stage I non‐small cell lung cancerJournal of Medical Imaging and Radiation Oncology, 2012
- Inoperable early stage non-small cell lung cancer: Comorbidity, patterns of care and survivalLung Cancer, 2011
- Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend AnalysisJournal of Clinical Oncology, 2010
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJama-Journal Of The American Medical Association, 2010
- Local Control and Survival Following Concomitant Chemoradiotherapy in Inoperable Stage I Non-Small-Cell Lung CancerInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Review of Hypofractionated Small Volume Radiotherapy for Early-stage Non-small Cell Lung CancerClinical Oncology, 2008
- Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional StudyJournal of Thoracic Oncology, 2007
- Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung CancerJournal of Clinical Oncology, 2006